Oct 7 (Reuters) - Cell Impact AB CIb.ST :
* SAID ON TUESDAY RESOLVED ON DIRECTED ISSUE OF 7,000,000
SERIES B
SHARES AT A SUBSCRIPTION PRICE OF SEK 25 PER SHARE
* CO RAISED SEK 175,000,000 BEFORE TRANSACTION COSTS
* TOGETHER WITH EXISTING CASH, PROCEEDS FROM THE SHARE ISSUE
ARE
EXPECTED TO BE SUFFICIENT TO FINANCE CO'S BUSINESS PLAN TO THE
BEGINNING OF 2022
* SUBSCRIPTION PRICE IN THE SHARE ISSUE CORRESPONDS TO A
DISCOUNT
OF APPROXIMATELY 6.7 PERCENT COMPARED TO THE CLOSING PRICE ON
NASDAQ FIRST NORTH GROWTH MARKET AS OF OCTOBER 6, 2020
Source text for Eikon: urn:newsml:reuters.com:*:nBQN8Nd96j
Further company coverage: CIb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))